{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:30:08Z","timestamp":1788791408748,"version":"build-2803163510"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Bladder\/prostate rhabdomyosarcoma (BP-RMS) is a challenging clinical entity within pediatric genitourinary oncology. While historical management relied on radical extirpative surgery, the contemporary paradigm has shifted toward multimodal therapy combining chemotherapy, radiation, and organ-sparing surgery to maximize bladder preservation. This review examines the current landscape of BP-RMS diagnosis, molecular risk stratification, and surgical management, with a particular emphasis on multidisciplinary surgical collaboration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Outcomes for BP-RMS have improved through cooperative group trials (COG, SIOP, EpSSG), though functional bladder outcomes remain suboptimal despite organ preservation. Risk stratification has evolved to prioritize PAX-FOXO1 fusion status over histology alone, as fusion-positive tumors demonstrate more aggressive behavior. Surgical management now favors biopsy followed by delayed primary excision or radiation rather than upfront resection. Collaboration between pediatric urology and pediatric surgery in the surgical management of patients with BP-RMS may aid in optimizing oncologic outcomes, minimize trial protocol deviations, inadvertent upstaging, and reduce cognitive load during complex resections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>BP-RMS requires nuanced management that balances oncologic control with long-term functional quality of life. The high complexity of pelvic surgery and the risks of inadvertent upstaging necessitate a cohesive, multidisciplinary surgical team to navigate the anatomical and therapeutic challenges of this disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mop.0000000000001604","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:00:12Z","timestamp":1787565612000},"page":"531-537","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Modern management and multidisciplinary care of bladder prostate rhabdomyosarcoma"],"prefix":"10.1097","volume":"38","author":[{"given":"Andrew T.","family":"Gabrielson","sequence":"first","affiliation":[{"name":"Department of Pediatric Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Grabski","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy B.","family":"Lautz","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward M.","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Pediatric Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"R1-20260907","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0051-2","article-title":"Rhabdomyosarcoma","volume":"5","author":"Skapek","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20260907","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.urology.2024.08.041","article-title":"Pediatric urologic oncology series-bladder\/prostate rhabdomyosarcoma","volume":"193","author":"Gabrielson","year":"2024","journal-title":"Urology"},{"issue":"Pt 1","key":"R3-20260907","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.juro.2006.06.019","article-title":"Bladder\/prostate rhabdomyosarcoma: past, present and future","volume":"176","author":"Ferrer","year":"2006","journal-title":"J Urol"},{"key":"R4-20260907","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/ijc.25444","article-title":"Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder\/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee","volume":"128","author":"Rodeberg","year":"2011","journal-title":"Int J Cancer"},{"key":"R5-20260907","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/pbc.24727","article-title":"Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95","volume":"61","author":"Jenney","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"6 Pt 1","key":"R6-20260907","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1097\/01.ju.0000127752.41749.a4","article-title":"Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder\/prostate rhabdomyosarcoma? Results from intergroup rhabdomyosarcoma study iv","volume":"171","author":"Arndt","year":"2004","journal-title":"J Urol"},{"key":"R7-20260907","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1002\/cncr.24465","article-title":"Trends in childhood rhabdomyosarcoma incidence and survival in the United States","volume":"115","author":"Ognjanovic","year":"2009","journal-title":"Cancer"},{"key":"R8-20260907","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bjc.6605484","article-title":"Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype","volume":"102","author":"Ognjanovic","year":"2010","journal-title":"Br J Cancer"},{"key":"R9-20260907","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1158\/1055-9965.EPI-08-0775","article-title":"Prenatal X-ray exposure and rhabdomyosarcoma in children: a report from the children's oncology group","volume":"18","author":"Grufferman","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R10-20260907","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ijc.28363","article-title":"Allergies, atopy, immune-related factors and childhood rhabdomyosarcoma: a report from the Children's Oncology Group","volume":"134","author":"Lupo","year":"2014","journal-title":"Int J Cancer"},{"key":"R11-20260907","doi-asserted-by":"crossref","first-page":"747","DOI":"10.7326\/0003-4819-71-4-747","article-title":"Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?","volume":"71","author":"Li","year":"1969","journal-title":"Ann Intern Med"},{"key":"R12-20260907","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/gepi.1370120504","article-title":"Association of childhood rhabdomyosarcoma with neurofibromatosis type I and birth defects","volume":"12","author":"Yang","year":"1995","journal-title":"Genet Epidemiol"},{"key":"R13-20260907","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jpeds.2004.02.026","article-title":"Neurofibromatosis in children with Rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma study IV","volume":"144","author":"Sung","year":"2004","journal-title":"J Pediatr"},{"key":"R14-20260907","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/08880018809031246","article-title":"Neurofibromatosis in children with soft tissue sarcoma","volume":"5","author":"Hartley","year":"1988","journal-title":"Pediatr Hematol Oncol"},{"key":"R15-20260907","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ejhg.2011.37","article-title":"Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation","volume":"19","author":"Jongmans","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"R16-20260907","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/MOP.0b013e3282f161dc","article-title":"Costello syndrome and related disorders","volume":"19","author":"Quezada","year":"2007","journal-title":"Curr Opin Pediatr"},{"key":"R17-20260907","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/pbc.22591","article-title":"Metastatic alveolar rhabdomyosarcoma in multiple endocrine neoplasia type 2A","volume":"55","author":"Jones","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R18-20260907","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1158\/1078-0432.CCR-17-3089","article-title":"DICER1 and associated conditions: identification of at-risk individuals and recommended surveillance strategies","volume":"24","author":"Schultz","year":"2018","journal-title":"Clin Cancer Res"},{"key":"R19-20260907","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1016\/j.jss.2011.03.001","article-title":"Rhabdomyosarcoma in children: a SEER population based study","volume":"170","author":"Perez","year":"2011","journal-title":"J Surg Res"},{"key":"R20-20260907","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/PAP.0b013e3182a92d0d","article-title":"Classification of rhabdomyosarcoma and its molecular basis","volume":"20","author":"Parham","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"R21-20260907","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1200\/JCO.2012.44.6476","article-title":"Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee","volume":"31","author":"Weiss","year":"2013","journal-title":"J Clin Oncol"},{"key":"R22-20260907","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/pbc.24118","article-title":"Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies","volume":"59","author":"Malempati","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"R23-20260907","first-page":"5108","article-title":"Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma","volume":"53","author":"Shapiro","year":"1993","journal-title":"Cancer Res"},{"key":"R24-20260907","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/ng1193-230","article-title":"Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma","volume":"5","author":"Galili","year":"1993","journal-title":"Nat Genet"},{"key":"R25-20260907","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/pbc.25862","article-title":"Histology, fusion status, and outcome in alveolar rhabdomyosarcoma with low-risk clinical features: a report from the Children's Oncology Group","volume":"63","author":"Arnold","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"R26-20260907","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1002\/cam4.2504","article-title":"Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: a report from the Children's Oncology Group","volume":"8","author":"Hibbitts","year":"2019","journal-title":"Cancer Med"},{"key":"R27-20260907","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ejca.2022.05.036","article-title":"Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: a consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe","volume":"172","author":"Hettmer","year":"2022","journal-title":"Eur J Cancer"},{"key":"R28-20260907","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.22.00409","article-title":"Circulating tTumor DNA is prognostic in intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group","volume":"41","author":"Abbou","year":"2023","journal-title":"J Clin Oncol"},{"key":"R29-20260907","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ucl.2004.04.004","article-title":"Pediatric urologic oncology: bladder, prostate, testis","volume":"31","author":"Wu","year":"2004","journal-title":"Urol Clin N Am"},{"key":"R30-20260907","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.3390\/cancers15102864","article-title":"Pediatric rhabdomyosarcomas of the genitourinary tract","volume":"15","author":"Castle","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R31-20260907","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.jpedsurg.2004.08.003","article-title":"Urinary diversion in children with pelvic tumors","volume":"39","author":"Meir","year":"2004","journal-title":"J Pediatr Surg"},{"key":"R32-20260907","doi-asserted-by":"crossref","first-page":"e006030","DOI":"10.1136\/bmjopen-2014-006030","article-title":"An emerging evidence base for PET-CT in the management of childhood rhabdomyosarcoma: systematic review","volume":"5","author":"Norman","year":"2015","journal-title":"BMJ Open"},{"key":"R33-20260907","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejca.2021.07.006","article-title":"Role of (18)F-FDG-PET\/CT in the staging of metastatic rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group","volume":"155","author":"Mercolini","year":"2021","journal-title":"Eur J Cancer"},{"key":"R34-20260907","doi-asserted-by":"crossref","first-page":"e29644","DOI":"10.1002\/pbc.29644","article-title":"Clinical group and modified TNM stage for rhabdomyosarcoma: a review from the Children's Oncology Group","volume":"69","author":"Crane","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"R35-20260907","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-3468(89)80290-8","article-title":"Primary reexcision for patients with \u2019microscopic residual\u2019 tumor following initial excision of sarcomas of trunk and extremity sites","volume":"24","author":"Hays","year":"1989","journal-title":"J Pediatr Surg"},{"key":"R36-20260907","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/cncr.33275","article-title":"Benefit of delayed primary excision in rhabdomyosarcoma: a report from the Children's Oncology Group","volume":"127","author":"Lautz","year":"2021","journal-title":"Cancer"},{"key":"R37-20260907","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00247-023-05596-8","article-title":"Imaging in rhabdomyosarcoma: a patient journey","volume":"53","author":"de Vries","year":"2023","journal-title":"Pediatr Radiol"},{"key":"R38-20260907","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/cncr.32603","article-title":"Is surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experience","volume":"126","author":"Vaarwerk","year":"2020","journal-title":"Cancer"},{"key":"R39-20260907","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/ijc.32896","article-title":"Relationship between tumor response at therapy completion and prognosis in patients with Group III rhabdomyosarcoma: a report from the Children's Oncology Group","volume":"147","author":"Lautz","year":"2020","journal-title":"Int J Cancer"},{"key":"R40-20260907","doi-asserted-by":"crossref","first-page":"162610","DOI":"10.1016\/j.jpedsurg.2025.162610","article-title":"Too many cooks in the kitchen or an organized brigade? A success story of collaboration between pediatric urology and surgery to treat children with renal tumors","volume":"60","author":"Spencer","year":"2025","journal-title":"J Pediatr Surg"},{"key":"R41-20260907","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/JU.0000000000003971","article-title":"Multi-institutional bladder exstrophy consortium after 8 years: the short- and intermediate-term outcomes","volume":"212","author":"Weiss","year":"2024","journal-title":"J Urol"},{"key":"R42-20260907","doi-asserted-by":"crossref","first-page":"162103","DOI":"10.1016\/j.jpedsurg.2024.162103","article-title":"Satisfaction with multidisciplinary team structure and function in a pediatric outpatient clinic","volume":"60","author":"Moodley","year":"2025","journal-title":"J Pediatr Surg"},{"key":"R43-20260907","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/UPJ.0000000000000258","article-title":"Satisfaction and shared decision making in a multidisciplinary care clinic for patients with differences in sex development","volume":"8","author":"Grande","year":"2021","journal-title":"Urol Pract"},{"key":"R44-20260907","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.wneu.2024.05.051","article-title":"Dual versus single attending surgeon performance of spinal deformity surgery? A meta-analysis","volume":"188","author":"Daher","year":"2024","journal-title":"World Neurosurg"},{"key":"R45-20260907","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.5435\/JAAOS-D-17-00717","article-title":"Two surgeon approach for complex spine surgery: rationale, outcome, expectations, and the case for payment reform","volume":"27","author":"Bauer","year":"2019","journal-title":"J Am Acad Orthop Surg"},{"key":"R46-20260907","doi-asserted-by":"crossref","first-page":"e29924","DOI":"10.1002\/pbc.29924","article-title":"Creating a data commons: the INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT)","volume":"69","author":"Wyatt","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"R47-20260907","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S1470-2045(24)00255-9","article-title":"Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group","volume":"25","author":"Gupta","year":"2024","journal-title":"Lancet Oncol"},{"key":"R48-20260907","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijrobp.2025.03.038","article-title":"Radiation therapy dose escalation failed to improve local control for intermediate-risk rhabdomyosarcoma on ARST1431: a report from the Children's Oncology Group","volume":"123","author":"Jackson","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R49-20260907","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jamaoncol.2024.6812","article-title":"The children's oncology group long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers: a review","volume":"11","author":"DeVine","year":"2025","journal-title":"JAMA Oncol"},{"key":"R50-20260907","doi-asserted-by":"crossref","first-page":"e27652","DOI":"10.1002\/pbc.27652","article-title":"Rhabdomyosarcoma diagnosed in the first year of life: localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS)","volume":"66","author":"Sparber-Sauer","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"R51-20260907","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.juro.2006.07.064","article-title":"Late effects in 164 patients with rhabdomyosarcoma of the bladder\/prostate region: a report from the international workshop","volume":"176","author":"Raney","year":"2006","journal-title":"J Urol"},{"key":"R52-20260907","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1097\/JU.0000000000003393","article-title":"Long-term urological outcomes in pelvic genitourinary rhabdomyosarcoma: a 48-year single-center experience","volume":"209","author":"Wang","year":"2023","journal-title":"J Urol"},{"key":"R53-20260907","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1200\/JCO.2005.12.096","article-title":"Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors","volume":"23","author":"Spunt","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0000000000001604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:00:39Z","timestamp":1788789639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0000000000001604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001604","relation":{},"ISSN":["1531-698X","1040-8703"],"issn-type":[{"value":"1531-698X","type":"electronic"},{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,24]]}}}